Press Release: Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026 PARIS, France – February 21, 2026 – 12:00 PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing…
Photo courtesy of Alice Waddington & Paul Christian PR Art courtesy of Neotext LOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Neotext, the digital fiction imprint purpose-built to develop original IP for screen adaptation, has announced that director Alice Waddington is set to co-write and direct a feature film adaptation of Anonymous Jane, the action-spy…
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Class A common stock of NuScale Power Corporation (NYSE: SMR) between May 13, 2025 and November 6, 2025, inclusive (the “Class Period”). A class action lawsuit has…
PHILADELPHIA, Feb. 20, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against NuScale Power Corporation (NYSE: SMR) (“NuScale” or the “Company”) on behalf of investors who purchased or otherwise acquired NuScale securities during the period from May 13, 2025 through November 6, 2025…
SAN FRANCISCO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Inscope, the AI-powered financial reporting platform built for accounting firms and enterprises, today announced it has raised $14.5 million in Series A funding. The round was led by Norwest, with participation from Storm Ventures, existing investors Better Tomorrow Ventures and Lightspeed Venture Partners, and strategic operators across…
